Australian Clinical Labs Limited (ASX:ACL)

Australian Clinical Labs Revenue

In the fiscal year ending June 30, 2025, Australian Clinical Labs had annual revenue of 741.27M AUD with 6.45% growth. Australian Clinical Labs had revenue of 372.10M in the half year ending June 30, 2025, with 10.49% growth.

• Revenue: 741.27M
• Revenue Growth: +6.45%
• P/S Ratio: 0.70
• Revenue / Employee: 157.72K
• Employees: 4,700
• Market Cap: 521.15M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	741.27M	44.90M	6.45%
Jun 30, 2024	696.37M	-704.00K	-0.10%
Jun 30, 2023	697.07M	-298.53M	-29.99%
Jun 30, 2022	995.60M	348.90M	53.95%
Jun 30, 2021	646.70M	156.13M	31.83%